<DOC>
	<DOCNO>NCT01750268</DOCNO>
	<brief_summary>The goal propose project improve treatment veteran co-occurring traumatic brain injury ( TBI ) hazardous harmful alcohol use . The PI coinvestigators conduct pilot control clinical trial topiramate treatment co-occurring disorder .</brief_summary>
	<brief_title>Topiramate Treatment Hazardous Harmful Alcohol Use Veterans With TBI</brief_title>
	<detailed_description />
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Inclusion Criteria 1 . Male female veteran . 2 . Ages 18 65 ( inclusive ) . 3 . TBI : history mild traumatic brain injury , define American Congress Rehabilitation Medicine ( ACRM ) VA , chronic , stable phase recovery ( &gt; 6 month injury ) . The ACRM define mild TBI traumaticallyinduced physiological disruption brain function demonstrate least one following : 3.a . loss consciousness 30 minute ; 3.b . loss memory event immediately event ; 3.c . alteration mental state time event , example feeling daze , disorient , confuse ; 3.d . focal neurological deficit deficit may may transient , example loss coordination , speech difficulty , double vision . ACRM 's definition specifies person may designate mild TBI severity injury include loss consciousness last long 30 minute , posttraumatic amnesia lasting longer 24 hour . Rationale : 1 . This common description patient currently serve VA facility . 2 . Studies stable phase facilitate detection otherwise subtle change finding less likely confound 'spontaneous ' recovery . 4 . Current ( past month ) hazardous alcohol use harmful alcohol use . 4.a . Hazardous use drinking must meet criterion `` atrisk '' `` heavy '' drink National Institute Alcohol Abuse Alcoholism ( NIAAA ) criterion : Subjects must report current ( past 30 day ) `` atrisk '' `` heavy '' drink average weekly basis , consist average 15 standard drink per week men 8 standard drink per week woman 30 day prior Screening Visit 1 measure Alcohol Timeline Followback ( TLFB ) method . 4.b . Harmful use drink behavior meet Diagnostic Statistical Manual ( DSM ) IV diagnostic criterion Alcohol Use Disorder ( Alcohol Dependence Alcohol Abuse ) . 5 . Subjects must express desire reduce stop alcohol use . 6 . Female subject must negative urine pregnancy test must either postmenopausal least 1 year practice effective method birth control ( e.g. , surgically sterile , spermicide barrier , male partner sterilization ; absent agrees continue abstinence use acceptable method contraception , list , sexual activity commence ) . 7 . Subjects must Breath Alcohol Concentration ( BAC ) less 0.02 % signing informed consent form . Exclusion Criteria 1 . Psychotic disorder , bipolar disorder , dementia , psychiatric disorder judge unstable . 2 . Subjects know clinically significant unstable medical condition , include limited : Clinically significant renal disease and/or impair renal function define clinically significant elevation blood urea nitrogen ( BUN ) creatinine estimate creatinine clearance &lt; 60 mL/min ; AST and/or ALT &gt; 5 time upper limit normal range and/or serum bilirubin &gt; 2 time upper limit normal . 3 . History glaucoma . 4 . History kidney stone . 5 . Concurrent participation another alcohol treatment study study involve medication . 6 . Female patient pregnant lactate . 7 . Topiramate use past week prior study entry . 8 . Use medication alcohol dependence ( disulfiram , naltrexone , acamprosate ) within past week . 9 . Needing acute medical detoxification alcohol base score 12 Clinical Institute Withdrawal Assessment Alcohol Scale ( CIWAAD ) . 10 . Subjects legally mandate participate alcohol treatment program . 11 . Subjects suicide attempt past 6 month suicidal ideation , intent , 30 day prior enrollment . 12 . Subjects previously treat topiramate reason discontinue treatment due adverse event due hypersensitivity reaction topiramate . 13 . Subjects seizure disorder . 14 . Subjects currently treat another anticonvulsant . 15 . Subjects opinion investigator enrol study precaution , warning contraindication outline topiramate package insert .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>TBI</keyword>
	<keyword>hazardous harmful alcohol use</keyword>
	<keyword>veteran</keyword>
	<keyword>co-occurring disorder</keyword>
	<keyword>pharmacotherapy</keyword>
</DOC>